Skip to main content

Merrimack Pharmaceuticals Inc

MACKDelisted May 10, 2024
Industry
Pharmaceutical Preparations
SEC CIK
0001274792

Merrimack Pharmaceuticals Inc was delisted on May 10, 2024; its insiders filed their last Form 4 on Dec 28, 2023; 70 institutions reported holding it in 13F filings for Q1 2024, worth $137.1M in total; no superinvestor held it.

13F holders, Q1 2023

Institutional positions in Merrimack Pharmaceuticals Inc as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
50
+3 vs. Q4 2022
Shares held
7.40M
−152.9K (−2.0%) vs. Q4 2022
Total value
$91.0M
+$4.41M (+5.1%) vs. Q4 2022
New holders
10
14 more added
Sold out
7
9 more reduced

Compare with Q4 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting MACK on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2023: 50 institutions
Q1 2021: 43 institutionsQ2 2021: 42 institutionsQ3 2021: 38 institutionsQ4 2021: 37 institutionsQ1 2022: 40 institutionsQ2 2022: 42 institutionsQ3 2022: 41 institutionsQ4 2022: 47 institutionsQ1 2023: 50 institutionsQ2 2023: 62 institutionsQ3 2023: 63 institutionsQ4 2023: 67 institutionsQ1 2024: 70 institutionsQ2 2024: 12 institutionsQ3 2024: 2 institutionsQ4 2024: 2 institutionsQ1 2025: 1 institutionQ2 2025: 1 institutionQ3 2025: 1 institutionQ4 2025: 1 institutionQ1 2026: 1 institutionQ2 2026: 1 institution
Value heldQ1 2023: $91.0M
Q1 2021: $49.8MQ2 2021: $50.3MQ3 2021: $37.1MQ4 2021: $29.3MQ1 2022: $49.4MQ2 2022: $48.0MQ3 2022: $30.0MQ4 2022: $86.6MQ1 2023: $91.0MQ2 2023: $98.5MQ3 2023: $104.4MQ4 2023: $124.9MQ1 2024: $137.1MQ2 2024: $5.32MQ3 2024: $0Q4 2024: $370.7KQ1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding MACK and their total value by quarter
QuarterHoldersValue
Q2 20261$0
Q1 20261$0
Q4 20251$0
Q3 20251$0
Q2 20251$0
Q1 20251$0
Q4 20242$370.7K
Q3 20242$0
Q2 202412$5.32M
Q1 202470$137.1M
Q4 202367$124.9M
Q3 202363$104.4M
Q2 202362$98.5M
Q1 202350$91.0M
Q4 202247$86.6M
Q3 202241$30.0M
Q2 202242$48.0M
Q1 202240$49.4M
Q4 202137$29.3M
Q3 202138$37.1M
Q2 202142$50.3M
Q1 202143$49.8M

Institutions, Q1 2023

Shares, value and share of portfolio for each institution holding Merrimack Pharmaceuticals Inc; share changes are against Q4 2022.

Institutions holding MACK in Q1 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Royal Bank of Canada8$00.00%00.0%Unchanged
AdvisorNet Financial, Inc20$2460.00%00.0%Unchanged
Armstrong Advisory Group, Inc45$5540.00%00.0%Unchanged
Horrell Capital Management, Inc.50$1.00K0.00%00.0%Unchanged
Federated Hermes, Inc.90$1.11K0.00%00.0%Unchanged
TSFG, LLC160$2.00K0.00%00.0%Unchanged
Wells Fargo & Company170$2.09K0.00%+2+1.2%Added
FMR LLC170$2.09K0.00%+170New
Rise Advisors, LLC272$3.34K0.00%00.0%Unchanged
Kayne Anderson Rudnick Investment Management LLC300$3.69K0.00%00.0%Unchanged
Sandy Spring Bank300$3.69K0.00%00.0%Unchanged
Baldwin Brothers Inc500$6.14K0.00%00.0%Unchanged
Dark Forest Capital Management LP1,060$13.0K0.00%+1,060New
Tower Research Capital LLC (TRC)1,235$15.0K0.00%−2,007−61.9%Reduced
GWM Advisors LLC1,406$17.3K0.00%00.0%Unchanged
Bank of America Corp1,493$18.3K0.00%−186−11.1%Reduced
Webster Bank, N. A.1,527$18.8K0.00%00.0%Unchanged
Dorsey Wright & Associates1,799$22.1K0.01%+1,799New
UBS Group AG3,128$38.4K0.00%+2,353+303.6%Added
Lazard Asset Management LLC4,951$60.0K0.00%+4,951New
Mascoma Wealth Management LLC5,000$62.0K0.02%00.0%Unchanged
Barclays PLC5,438$66.8K0.00%+5,303+3,928.1%Added
Citadel Advisors LLC8,491$104.4K0.00%+8,491New
Belvedere Trading LLC10,888$133.8K0.06%−28,102−72.1%Reduced
Kennedy Capital Management, Inc.13,758$169.1K0.00%+13,758New
Brown Advisory Inc15,029$184.7K0.00%00.0%Unchanged
Northern Trust Corp27,948$343.5K0.00%+2,126+8.2%Added
Bridgeway Capital Management, LLC34,200$420.3K0.01%00.0%Unchanged
Goldman Sachs Group Inc34,898$428.9K0.00%+20,756+146.8%Added
Jane Street Group, LLC37,307$458.5K0.00%+37,307New
Millennium Management LLC40,204$494.0K0.00%+23,219+136.7%Added
State Street Corp50,556$621.3K0.00%+1,700+3.5%Added
Morgan Stanley54,160$665.6K0.00%+44,997+491.1%Added
Yakira Capital Management, Inc.72,118$886.3K0.23%−13,614−15.9%Reduced
Bank of New York Mellon Corp74,880$920.3K0.00%00.0%Unchanged
Marshall Wace, LLP98,255$1.21M0.00%+98,255New
Boothbay Fund Management, LLC117,436$1.44M0.04%+53,225+82.9%Added
Geode Capital Management, LLC130,164$1.60M0.00%−4,062−3.0%Reduced
Susquehanna International Group, LLP138,995$1.71M0.00%−116,341−45.6%Reduced
Nantahala Capital Management, LLC191,266$2.35M0.23%−18,734−8.9%Reduced
Wittenberg Investment Management, Inc.197,994$2.43M0.91%+6,800+3.6%Added
Invesco Ltd.210,507$2.59M0.00%+210,507New
BlackRock Inc.222,253$2.73M0.00%+12,495+6.0%Added
Sio Capital Management, LLC272,843$3.35M1.66%+22,843+9.1%Added
Sepio Capital, LP294,545$3.62M0.33%00.0%Unchanged
Vanguard Group Inc458,521$5.64M0.00%−129,500−22.0%Reduced
Dimensional Fund Advisors LP466,140$5.73M0.00%−5,233−1.1%Reduced
Madison Avenue Partners, LP553,085$6.80M1.46%+553,085New
Western Standard LLC1,672,463$20.6M20.85%+142,969+9.3%Added
Newtyn Management, LLC1,873,694$23.0M4.52%+105,300+6.0%Added
22NW, LP0$00.00%−1,015,048−100.0%Sold out
OrbiMed Advisors LLC0$00.00%−73,600−100.0%Sold out
Pura Vida Investments, LLC0$00.00%−64,100−100.0%Sold out
Two Sigma Investments, LP0$00.00%−42,490−100.0%Sold out
Two Sigma Advisers, LP0$00.00%−11,181−100.0%Sold out
Freedom Wealth Alliance, LLC0$00.00%−1,820−100.0%Sold out
JPMorgan Chase & Co0$00.00%−354−100.0%Sold out